Cannabinoids are compounds that can activate two types of receptors within the ECS: CB1 receptors, which are located within the nervous system, brain, and nerve endings; and CB2 receptors, located primarily within the immune system. Targeting the ECS has been found to have anti-inflammatory, anticachexia, metabolic, pain management, antiseizure, and sleep-promoting effects.
